Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Former drug firm exec sentenced to more than 2 years for illegal opioid sales

Published 03/08/2023, 01:03 PM
Updated 03/08/2023, 02:16 PM
© Reuters. FILE PHOTO: Laurence Doud III, former CEO of Rochester Drug Co-Operative, exits the Manhattan Federal Courthouse in New York, U.S., April 23, 2019. REUTERS/Brendan McDermid/File Photo

By Brendan Pierson

NEW YORK (Reuters) -The former chief executive of Rochester Drug Co-operative was sentenced to more than two years in prison on Wednesday for conspiring to distribute opioids illegally, in the first criminal opioid trafficking case against a drug wholesaler and its executives.

U.S. District Judge George Daniels sentenced Laurence Doud, 79, to 27 months at a hearing in Manhattan. Daniels said Doud's crime was serious and "motivated solely by profit," but that the government's requested sentence of 15 years was more than needed.

Daniels ruled that Doud may remain free on bail while he appeals his conviction to the 2nd U.S. Circuit Court of Appeals.

"Laurence Doud cared more about his own paycheck than his responsibility... to prevent dangerous opioids from making their way to pharmacies, drug dealers and people struggling with addiction," U.S. Attorney Damian Williams said in a statement.

Robert Gottlieb, one of Doud's attorneys, called the sentence "very thoughtful and appropriate."

Gottlieb had argued during the sentencing hearing that Doud should avoid jail entirely because he did not intend drugs to be sold illegally.

Doud himself, before being sentenced, told the judge that he had "no desire to see anyone be hurt."

"I recognize what a lousy job I did," he said. "I am forever sorry for the problems that have occurred because of this."

Rochester Drug Co-operative (RDC), Doud and another executive were charged in 2019 with conspiring to distribute illegal narcotics and accused of ignoring clear red flags that the drugs were being sold illegally, such as large bulk orders of pills and payments in cash.

Doud was convicted in February 2022. The other executive, Chief Compliance Officer William Pietruszewski, pleaded guilty and testified against Doud. He is scheduled to be sentenced on March 29.

© Reuters. FILE PHOTO: Laurence Doud III, former CEO of Rochester Drug Co-Operative, exits the Manhattan Federal Courthouse in New York, U.S., April 23, 2019. REUTERS/Brendan McDermid/File Photo

RDC, which filed for bankruptcy in 2020, agreed in 2019 to pay $20 million to settle criminal and civil charges related to its opioid sales.

More than half a million people died from drug overdoses in the United States in the period from 1999 to 2020, according to the U.S. Centers for Disease Control and Prevention.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.